Meizhong Jin

USPTO Granted Patents = 25 (Patent Applications = 16)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 9.1

ph-index = 9

Forward Citations = 195(Granted Patents)

Location History:

Farmingdale, NY (US) (2010)
Dix Hills, NY (US) (2011 - 2013)
East Northport, NY (US) (2014 - 2022)
Wellesley, MA (US) (2019 - 2024)

Company Filing History:

12 out of 290

Enanta Pharmaceuticals, Inc.

patents

9 out of 118

Osi Pharmaceuticals, Inc.

patents

4 out of 57

Arvinas Operations, Inc.

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12264157 - Compounds and methods for the enhanced degradation of targeted proteins (2025-04-01),

2. 12054493 - Hepatitis B antiviral agents (2024-08-06),

3. 11512083 - Compounds and methods for the enhanced degradation of targeted proteins (2022-11-29),

4. 11352351 - Compounds and methods for the targeted degradation of androgen receptor (2022-06-07),

5. 10934306 - Hepatitis B antiviral agents (2021-03-02),

6. 10738035 - Hepatitis B antiviral agents (2020-08-11),

7. 10730870 - Compounds and methods for the enhanced degradation of targeted proteins (2020-08-04),

8. 10702528 - Hepatitis B antiviral agents (2020-07-07),

9. 10640511 - Hepatitis B antiviral agents (2020-05-05),

10. 10538532 - Hepatitis B antiviral agents (2020-01-21),

11. 10442788 - Hepatitis B antiviral agents (2019-10-15),

12. 10301255 - Hepatitis B antiviral agents (2019-05-28),

13. 10280175 - Hepatitis B antiviral agents (2019-05-07),

14. 10189846 - Hepatitis B antiviral agents (2019-01-29),

15. 10179792 - Hepatitis B antiviral agents (2019-01-15),

Title: Biography of Meizhong Jin

Introduction: Meizhong Jin is a prominent inventor based in Dix Hills, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that enhance the degradation of targeted proteins. With a total of 13 patents to his name, Jin's work has the potential to impact various therapeutic areas.

Latest Patents: One of his latest patents focuses on bifunctional compounds that serve as modulators of targeted ubiquitination. These compounds are designed to inhibit a variety of polypeptides and proteins that are degraded by the compounds. The invention involves a VHL ligand that binds to the ubiquitin ligase and a moiety that binds to a target protein, facilitating its degradation. This innovative approach exhibits a broad range of pharmacological activities, showcasing the potential of these compounds in therapeutic applications.

Career Highlights: Throughout his career, Meizhong Jin has worked with notable companies in the pharmaceutical industry. He has been associated with Osi Pharmaceuticals, Inc. and Arvinas Operations, Inc., where he has contributed to groundbreaking research and development efforts.

Collaborations: Jin has collaborated with esteemed colleagues, including Jing Wang and Andrew Philip Crew. These partnerships have further enriched his research and have led to advancements in the field of protein degradation.

Conclusion: Meizhong Jin's innovative work in the development of

This text is generated by artificial intelligence and may not be accurate.